🇺🇸 FDA

Drug profile · INN

copper histidinate

ZYCUBO

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

copper histidinate (ZYCUBO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN copper histidinate
Brand ZYCUBO
Route SUBCUTANEOUS
Formulation POWDER

Frequently asked questions

What is copper histidinate?

copper histidinate (ZYCUBO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for copper histidinate?

ZYCUBO is a marketed brand name for copper histidinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of copper histidinate?

copper histidinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.